Search Results - "Woolfenden, Amber"
-
1
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
Published in Cell (17-06-2005)“…Injury models have suggested that the lung contains anatomically and functionally distinct epithelial stem cell populations. We have isolated such a regional…”
Get full text
Journal Article -
2
Primary Tumor Genotype Is an Important Determinant in Identification of Lung Cancer Propagating Cells
Published in Cell stem cell (02-07-2010)“…Successful cancer therapy requires the elimination or incapacitation of all tumor cells capable of regenerating a tumor. Therapeutic advances therefore…”
Get full text
Journal Article -
3
Pharmacologic Uncoupling of Angiogenesis and Inflammation during Initiation of Pathological Corneal Neovascularization
Published in The Journal of biological chemistry (30-12-2011)“…Pathological neovascularization occurs when a balance of pro- and anti-angiogenic factors is disrupted, accompanied by an amplifying inflammatory cascade…”
Get full text
Journal Article -
4
Lack of involvement of CEP adducts in TLR activation and in angiogenesis
Published in PloS one (24-10-2014)“…Proteins that are post-translationally adducted with 2-(ω-carboxyethyl)pyrrole (CEP) have been proposed to play a pathogenic role in age-related macular…”
Get full text
Journal Article -
5
Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation
Published in Investigative ophthalmology & visual science (09-09-2014)“…We attempted to reproduce published studies that evaluated whether the following factors influence choroidal neovascularization (CNV) induced by laser…”
Get full text
Journal Article -
6
The Discovery of N‑(1-Methyl-5-(trifluoromethyl)‑1H‑pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)‑1H‑indole-1-carboxamide (Acrizanib), a VEGFR‑2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration
Published in Journal of medicinal chemistry (22-02-2018)“…A noninvasive topical ocular therapy for the treatment of neovascular or “wet” age-related macular degeneration would provide a patient administered…”
Get full text
Journal Article -
7
Discovery of Oral VEGFR‑2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration
Published in Journal of medicinal chemistry (10-12-2015)“…The benefit of intravitreal anti-VEGF therapy in treating wet age-related macular degeneration (AMD) is well established. Identification of VEGFR-2 inhibitors…”
Get full text
Journal Article -
8
The Discovery of N -(1-Methyl-5-(trifluoromethyl)-1 H -pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1 H -indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration
Published in Journal of medicinal chemistry (22-02-2018)Get full text
Journal Article